Revenue $4.12B, down 1.0% on a year earlier. Aflac U.S. new annualized premium sales $349.00M, up 2.6%. Diluted EPS $1.63 against $1.11.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $4.12B | $4.35B | $4.16B | -1.0% |
| Operating income | $995.00M | $1.23B | $822.00M | +21.0% |
| Net income | $825.00M | $1.02B | $599.00M | +37.7% |
| Diluted EPS | $1.63 | $1.98 | $1.11 | |
| Operating cash flow | $112.00M | $968.00M | $399.00M | -71.9% |
| Dividend per share | $0.61 | — | $0.58 |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Aflac U.S. new annualized premium sales | $349.00M | $340.00M | +2.6% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Aflac (AFL) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/AFL/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.